open access

Online first
Short communication
Published online: 2021-12-16
Get Citation

HIV-infected patients on combined antiretroviral treatment had a similar level of arterial stiffness to the patients with ST-segment elevation myocardial infarction

Tomasz Mikuła12, Magdalena M Suchacz12, Michał Peller3, Paweł Balsam3, Łukasz Kołtowsk3, Renata Główczyńska3, Krzysztof J Filipiak3, Grzegorz Opolski3, Alicja Wiercińska-Drapało12
DOI: 10.33963/KP.a2021.0183
·
Pubmed: 34915591
Affiliations
  1. Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warszawa, Poland
  2. Hospital for Infectious Diseases, Warszawa Poland
  3. Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland

open access

Online first
Short communication
Published online: 2021-12-16

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

HIV-infected patients on combined antiretroviral treatment had a similar level of arterial stiffness to the patients with ST-segment elevation myocardial infarction

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2021-12-16

DOI

10.33963/KP.a2021.0183

Pubmed

34915591

Authors

Tomasz Mikuła
Magdalena M Suchacz
Michał Peller
Paweł Balsam
Łukasz Kołtowsk
Renata Główczyńska
Krzysztof J Filipiak
Grzegorz Opolski
Alicja Wiercińska-Drapało

References (12)
  1. Chow FC, Regan S, Feske S, et al. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012; 60(4): 351–358.
  2. Badejo OA, Chang CC, So-Armah KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013; 173(8): 614–622.
  3. Xu Y, Arora RC, Hiebert BM, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2014; 15(7): 736–746.
  4. Kikuya M, Asayama K, Ohkubo T. Blood pressure variability and arterial stiffness parameters derived from ambulatory blood pressure monitoring. Kardiol Pol. 2019; 77(5): 509–514.
  5. Nadel J, O'Dwyer E, Emmanuel S, et al. High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls. J Cardiovasc Comput Tomogr. 2016; 10(5): 391–397.
  6. EACS Treatment Guidelines version 10.1 Available online: www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html. [Access: November 2020].
  7. Triant VA, Perez J, Regan S, et al. Cardiovascular risk prediction functions underestimate risk in HIV infection. Circulation. 2018; 137(21): 2203–2214.
  8. Krikke M, Hoogeveen RC, Hoepelman AIM, et al. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models. HIV Med. 2016; 17(4): 289–297.
  9. Centers for Disease Control and Prevention: National Center for Health Statistics - National Health Interview Survey. Available online: www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm. [Access: November 2021].
  10. Knobel H, Domingo P, Suarez-Lozano I, et al. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin. 2019; 37(6): 373–379.
  11. Alvi RM, Neilan AM, Tariq N, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure. J Am Coll Cardiol. 2018; 72(5): 518–530.
  12. Morris PB, Ference BA, Jahangir E, et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 2015; 66(12): 1378–1391.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl